Celgem 200mg Injection 1s

Celgem 200mg Injection 1s works by transforming inside cancer cells, disrupting DNA formation, ultimately causing cancer cells to die

Celgem 200mg Injection 1s belongs to the class of chemotherapy medications used specifically in cancer treatment to inhibit cancer cell growth.

Celgem 200mg Injection 1s operates by converting within cancer cells, creating active compounds that interfere with DNA building. This interference leads to the termination of DNA chains, causing the breakdown of DNA and subsequent death of cancer cells Additionally, It has a unique ability to enhance its own effectiveness by reducing certain DNA building blocks, thus prolonging its impact within cancer cells.

This medication should be administered by healthcare professionals. Patients should not self administer this Follow the guidance of doctors or nurses for proper administration.

Common side effects of Gemcitabine may include nausea, vomiting, breathlessness, anemia (low red blood cell count), blood in urine, headache, fever, and diarrhea.

It may cause myelosuppression, leading to decreased blood cell counts Regular blood tests are necessary to monitor blood cell counts, and dosage adjustments may be required based on these results.

If a dose is missed, take it when remembered However, if the next dose is imminent, skip the missed one and continue with the regular dosing schedule Avoid doubling doses Consulting a doctor for guidance on managing missed doses effectively is recommended.